LINGARD; Iain

Patent Applications and Registrations

Patent applications and USPTO patent grants for LINGARD; Iain.The latest application filed is for "phenyltetrazole derivatives as plasma kallikrein inhibitors".

Company Profile

7.21.25

LINGARD; Iain - Monza IT
LINGARD; Iain - Verona IT
Lingard; Iain - Milan IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Phenyltetrazole Derivatives As Plasma Kallikrein Inhibitors App 20210387963 - WIEDENMAYER; Dieter ; et al.	2021-12-16
Heterocyclic Compounds As Delta-5 Desaturase Inhibitors And Methods Of Use App 20210221824 - ALLEN; Jennifer R. ; et al.	2021-07-22
Heterocyclic Compounds As Delta-5 Desaturase Inhibitors And Methods Of Use App 20210188874 - ALLEN; Jennifer R. ; et al.	2021-06-24
Heterocyclic Compounds As Delta-5 Desaturase Inhibitors And Methods Of Use App 20210171529 - ALLEN; Jennifer R. ; et al.	2021-06-10
Somatostatin receptor subtype 4 (SSTR4) agonists Grant 10,675,268 - Giovannini , et al.	2020-06-09
Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors Grant 10,640,486 - Frattini , et al.	2020-05-05
Morpholine and 1,4-oxazepane amides as somatostatin receptor subtype 4 (SSTR4) agonists Grant 10,577,336 - Mazzaferro , et al.	2020-03-03
Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors Grant 10,501,440 - Frattini , et al. Dec	2019-12-10
New Somatostatin Receptor Subtype 4 (sstr4) Agonists App 20190269650 - Giovannini; Riccardo ; et al.	2019-09-05
Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors Grant 10,399,961 - Frattini , et al. Sep	2019-09-03
Aryl and heteroaryl-fused tetrahydro-1,4-oxazepine amides as somatostatin receptor subtype 4 (SSTR4) agonists Grant 10,183,940 - Mazzaferro , et al. Ja	2019-01-22
Somatostatin receptor subtype 4 (SSTR4) agonists Grant 10,166,214 - Giovannini , et al. J	2019-01-01
Morpholine And 1,4-oxazepane Amides As Somatostatin Receptor Subtype 4 (sstr4) Agonists App 20180339971 - MAZZAFERRO; Rocco ; et al.	2018-11-29
Heteroarylcarboxamide Derivatives As Plasma Kallikrein Inhibitors App 20180319771 - FRATTINI; Sara ; et al.	2018-11-08
Heteroarylcarboxamide Derivatives As Plasma Kallikrein Inhibitors App 20180305338 - FRATTINI; Sara ; et al.	2018-10-25
Heteroarylcarboxamide Derivatives as Plasma Kallikrein Inhibitors App 20180305339 - FRATTINI; Sara ; et al.	2018-10-25
Aryl And Heteroaryl-fused Tetrahydro-1,4-oxazepine Amides As Somatostatin Receptor Subtype 4 (sstr4) Agonists App 20180291018 - MAZZAFERRO; Rocco ; et al.	2018-10-11
Morpholine and 1,4-oxazepane amides as somatostatin receptor subtype 4 (SSTR4) agonists Grant 10,071,974 - Mazzaferro , et al. September 11, 2	2018-09-11
Somatostatin Receptor Subtype 4 (sstr4) Agonists App 20180092880 - Giovannini; Riccardo ; et al.	2018-04-05
Morpholine And 1,4-oxazepane Amides As Somatostatin Receptor Subtype 4 (sstr4) Agonists App 20170320838 - MAZZAFERRO; Rocco ; et al.	2017-11-09
Somatostatin receptor subtype 4 (SSTR4) agonists Grant 9,789,082 - Giovannini , et al. October 17, 2	2017-10-17
New Somatostatin Receptor Subtype 4 (sstr4) Agonists App 20170014381 - Giovannini; Riccardo ; et al.	2017-01-19
Somatostatin receptor subtype 4 (SSTR4) agonists Grant 9,371,282 - Giovannini , et al. June 21, 2	2016-06-21
Indanyloxyphenylcyclopropanecarboxylic acids Grant 9,308,194 - Lingard , et al. April 12, 2	2016-04-12
Indanyloxyphenylcyclopropanecarboxylic Acids App 20150148347 - LINGARD; Iain ; et al.	2015-05-28
Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament Grant 9,012,489 - Giovannini , et al. April 21, 2	2015-04-21
New Somatostatin receptor subtype 4 (SSTR4) agonists App 20140343065 - GIOVANNINI; Riccardo ; et al.	2014-11-20
Bicyclic ring system substituted sulfonamide functionalised phenols as medicaments Grant 8,648,070 - Giovannini , et al. February 11, 2	2014-02-11
Bicyclic ring system substituted amide functionalised phenols as medicaments Grant 8,648,118 - Giovannini , et al. February 11, 2	2014-02-11
Indanyloxydihydrobenzofuranylacetic acids Grant 8,642,585 - Eckhardt , et al. February 4, 2	2014-02-04
Indanyloxyphenylcyclopropanecarboxylic acids Grant 8,633,182 - Hamprecht , et al. January 21, 2	2014-01-21
Indanyloxyphenylcyclopropanecarboxylic Acids App 20130324514 - HAMPRECHT; Dieter ; et al.	2013-12-05
New Indanyloxydihydrobenzofuranylacetic Acids App 20130252937 - ECKHARDT; Matthias ; et al.	2013-09-26
Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament App 20130197011 - GIOVANNINI; Riccardo ; et al.	2013-08-01
Bicyclic Ring System Substituted Amide Functionalised Phenols As Medicaments App 20120329773 - GIOVANNINI; Riccardo ; et al.	2012-12-27
Bicyclic Ring System Substituted Sulfonamide Functionalised Phenols As Medicaments App 20120316159 - GIOVANNINI; Riccardo ; et al.	2012-12-13
Pyrrole Derivatives as Positive Allosteric Modulators of Metabotropic Receptors App 20090203737 - Gagliardi; Stefania ; et al.	2009-08-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.